This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs). Its trifluoromethyl groups enhance the compound's metabolic stability and bioavailability, making it valuable in the development of medications targeting inflammation and pain management. Additionally, it is employed in organic synthesis to create complex molecules with specific pharmacological properties, particularly in the design of drugs that require high selectivity and potency. Its unique structure also makes it a candidate for research in the development of novel therapeutic agents for various diseases.